Glinil M

✅ Controls blood sugar
✅ Manages diabetes
✅ Enhances insulin sensitivity
✅ Reduces glucose levels
✅ Improves glycemic control

Glinil M contains Glibenclamide and Metformin.

Product Overview

Glinil M is a medication containing the active ingredients Glibenclamide and Metformin. This combination medication is designed to manage blood sugar levels in individuals with type 2 diabetes mellitus. Glibenclamide belongs to the sulfonylurea class of drugs, which stimulates the pancreas to produce more insulin and helps the body utilize insulin more effectively. Metformin is a biguanide that works by decreasing glucose production in the liver and improving insulin sensitivity in the muscles and tissues. Together, Glibenclamide and Metformin provide a comprehensive approach to controlling blood sugar levels in diabetic patients.


Glinil M is prescribed for the treatment of type 2 diabetes mellitus, particularly in individuals who are unable to achieve adequate glycemic control with diet and exercise alone. This medication helps lower blood sugar levels by increasing insulin secretion from the pancreas and reducing glucose production in the liver. Glinil M is indicated for use in adults and adolescents aged 12 years and older with type 2 diabetes.

How to Use

Glinil M should be taken orally with meals to reduce the risk of gastrointestinal side effects. The dosage and frequency of administration will be determined by a healthcare provider based on the patient’s blood sugar levels and response to treatment. It is important to follow the prescribed dosage regimen and not exceed the recommended maximum dose to avoid hypoglycemia (low blood sugar) or other adverse effects. Regular monitoring of blood sugar levels is necessary while taking Glinil M to ensure optimal glycemic control.

How it Works

Glibenclamide stimulates the release of insulin from pancreatic beta cells, leading to decreased blood sugar levels. It also enhances the sensitivity of peripheral tissues to insulin, allowing glucose to enter cells more efficiently. Metformin works by decreasing the amount of glucose produced by the liver and improving insulin sensitivity in muscle cells. Together, Glibenclamide and Metformin help regulate blood sugar levels in individuals with type 2 diabetes mellitus, reducing the risk of hyperglycemia and its associated complications.

Dosage and Administration

The dosage of Glinil M will be individualized based on the patient’s medical condition, kidney function, and response to treatment. The medication is typically initiated at a low dose and gradually titrated upwards to achieve optimal glycemic control. It is important to take Glinil M exactly as prescribed by a healthcare provider and not skip doses. Do not crush or chew the tablets; swallow them whole with a glass of water. If a dose is missed, take it as soon as remembered unless it is almost time for the next dose. Do not double the dose to catch up.


Glinil M offers several benefits in the management of type 2 diabetes mellitus. By combining Glibenclamide and Metformin, this medication provides dual mechanisms of action to lower blood sugar levels effectively. Glinil M helps improve insulin secretion and sensitivity, leading to better control of fasting and postprandial blood glucose levels. Additionally, this combination medication may reduce the risk of cardiovascular events and other complications associated with uncontrolled diabetes.

Common Side Effects

Common side effects of Glinil M may include nausea, vomiting, diarrhea, abdominal discomfort, headache, dizziness, and hypoglycemia. These side effects are usually mild to moderate in severity and may resolve with continued use of the medication. However, if any of these side effects persist or worsen, it is important to contact a healthcare provider for further evaluation. In rare cases, Glinil M may cause more serious adverse effects such as lactic acidosis or allergic reactions. Seek medical attention if experiencing any severe or unusual symptoms while taking this medication.


Glinil M should be used with caution in individuals with impaired kidney function, as Metformin may increase the risk of lactic acidosis, a serious condition characterized by the buildup of lactic acid in the bloodstream. This medication may also interact with certain drugs or medical conditions, so it is important to inform a healthcare provider about all medications, supplements, and medical conditions before starting treatment with Glinil M. Regular monitoring of kidney function and blood sugar levels is necessary while taking this medication.

Storage Information

Store Glinil M at room temperature away from moisture, heat, and light. Keep the medication out of reach of children and pets. Do not freeze Glinil M. Check the expiration date on the packaging and do not use the medication if it has expired. Dispose of any unused or expired medication properly according to local regulations.


Our sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover all possible side effects, drug interactions or warnings or alerts. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.

Additional Information


30 Tablet/s, 60 Tablet/s, 90 Tablet/s, 180 Tablet/s


There are no reviews yet.

Be the first to review “Glinil M”